Related Experiment Video
Updated: Jun 26, 2026

08:07
Single Molecule Fluorescence Energy Transfer Study of Ribosome Protein Synthesis
Published on: July 6, 2021
Stochastic gating and drug-ribosome interactions
Andrea C Vaiana1, Kevin Y Sanbonmatsu
1Theoretical Division, Los Alamos National Laboratory, Mail Stop K710, T-10, Los Alamos, NM 87545, USA.
Journal of Molecular Biology
|January 17, 2009
Summary
Gentamicin antibiotic action involves rapid ribosome decoding base flipping, preceding drug binding. This supports a stochastic gating mechanism, not induced fit, revealing complex drug-ribosome interactions.
Area of Science:
- Molecular Biology
- Computational Chemistry
- Pharmacology
Background:
- Gentamicin is a critical antibiotic for treating infections like anthrax and MRSA.
- Its mechanism involves disrupting bacterial ribosome function during mRNA decoding.
- Understanding the precise dynamics of gentamicin-ribosome interaction is key to antibiotic efficacy.
Purpose of the Study:
- To investigate the thermodynamics of the ribosomal decoding site.
- To elucidate the binding mechanism of gentamicin to the ribosome.
- To explore the free-energy landscape of drug-ribosome interactions.
Main Methods:
- Explicit solvent all-atom molecular simulation.
- Replica exchange molecular dynamics (REMD) simulations with 15 μs aggregate sampling.
- Free-energy landscape calculations, including enthalpic and entropic contributions.
Main Results:
- Ribosomal decoding bases exhibit conformational flipping on a timescale faster than gentamicin binding.
- This supports a stochastic gating mechanism for antibiotic binding.
- Drug dissociation involves navigating multiple metastable states, not a simple bound/unbound model.
Conclusions:
- Gentamicin binding to the ribosome follows a stochastic gating mechanism.
- The dynamic nature of the decoding site influences antibiotic interaction.
- Molecular simulations provide detailed insights into complex drug-ribosome thermodynamics.
Related Concept Videos
Translational Regulation
Translational regulation in prokaryotes ensures efficient protein synthesis by controlling ribosome access to mRNA. This regulation is mediated by secondary RNA structures, including translational riboswitches, RNA thermometers, and small RNAs (sRNAs), which respond to intracellular and environmental signals to modulate gene expression.Translational RiboswitchesRiboswitches in the leader region of mRNAs can regulate translation by altering the accessibility of the Shine-Dalgarno (SD) sequence,...
Directing Proteins to the Rough Endoplasmic Reticulum
The organelle-specific signaling sequences direct proteins synthesized in the cytosol to their final destination like ER, mitochondria, peroxisomes, etc. Some of the proteins directed to ER are then trafficked via vesicles to other organelles within the cell or the extracellular environment through the Golgi complex. For example, the rough ER synthesizes soluble proteins for transportation to the lysosomes or secretion out of the cell. It can also synthesize transmembrane proteins that can...
Types of RNA
Overview
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...
Cooperative Allosteric Transitions
Cooperative allosteric transitions can occur in multimeric proteins, where each subunit of the protein has its own ligand-binding site. When a ligand binds to any of these subunits, it triggers a conformational change that affects the binding sites in the other subunits; this can change the affinity of the other sites for their respective ligands. The ability of the protein to change the shape of its binding site is attributed to the presence of a mix of flexible and stable segments in the...
Cooperative Allosteric Transitions
Cooperative allosteric transitions can occur in multimeric proteins, where each subunit of the protein has its own ligand-binding site. When a ligand binds to any of these subunits, it triggers a conformational change that affects the binding sites in the other subunits; this can change the affinity of the other sites for their respective ligands. The ability of the protein to change the shape of its binding site is attributed to the presence of a mix of flexible and stable segments in the...
Riboswitches
Riboswitches are non-coding mRNA domains that regulate the transcription and translation of downstream genes without the help of proteins. Riboswitches bind directly to a metabolite and can form unique stem-loop or hairpin structures in response to the amount of the metabolite present. They have two distinct regions – a metabolite-binding aptamer and an expression platform.
The aptamer has high specificity for a particular metabolite which allows riboswitches to specifically regulate...
The aptamer has high specificity for a particular metabolite which allows riboswitches to specifically regulate...

